Skip to main content
2025 CNSF Congress Main banner
Final Program


Calendar-of-Events
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Industry Supported Session

Lunch 'n Learn: Navigating the Uncharted in Rare Neurological Disorders

Wednesday, June 11, 2025
12:00 PM – 1:30 PM ET

Audience:

Adult Neurologist, Child Neurologist, Neurosurgeon, Neurophysiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Audience response system, Case studies, Lecture/plenary method, Question and answer sessions

CanMEDs Roles:

Medical Expert, Scholar, Collaborator, Leader, Health Advocate

Join us at the CNSF conference for a compelling lunch and learn symposium, focusing on Generalized Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder, Neurofibromatosis Type 1, and Hereditary Transthyretin Amyloidosis. Led by a panel of leading experts in each field, this session will explore the diagnostic and management strategies for these rare neurological disorders.

This program was developed by the CNSF and Alexion AstraZeneca Rare Disease and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.

Learning Objectives:

  • Examine recent long-term evidence and real-world experience of Complement-5 (C5) inhibitors in the management of Generalized Myasthenia Gravis (gMG)
  • Understand the diagnosis and referral process for Neurofibromatosis Type 1 (NF1) patients within the Canadian healthcare system
  • Enhance diagnostic and patient management strategies in ATTR Amyloidosis to improve overall patient outcomes
  • Recognize the impact of biologic use in reducing relapse risk and improving patient outcomes in AQP4-positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Presentations:

  • 12:00 PM – 12:05 PM ET
    Introduction

    Speaker: Michael Nicolle, MD FRCPC DPhil – London Health Sciences Centre

  • 12:05 PM – 12:25 PM ET
    gMG + Q&A

    Speaker: Michael Nicolle, MD FRCPC DPhil – London Health Sciences Centre

  • 12:25 PM – 12:45 PM ET
    NF1 + Q&A

    Speaker: Vijay Ramaswamy, MD PhD FRCPC – The Hospital for Sick Children, Toronto

  • 12:45 PM – 1:05 PM ET
    ATTR Amyloidosis + Q&A

    Faculty: Michelle Mezei, MD, FRCPC – The University of British Columbia

  • 1:05 PM – 1:25 PM ET
    NMOSD + Q&A

    Speaker: Mark S. Freedman, MSc MD FRCPC (CSPQ FAAN FANA) – University of Ottawa

  • 1:25 PM – 1:30 PM ET
    Overall Q&A

    Speaker: Michael Nicolle, MD FRCPC DPhil – London Health Sciences Centre

    Speaker: Mark S. Freedman, MSc MD FRCPC (CSPQ FAAN FANA) – University of Ottawa

    Speaker: Vijay Ramaswamy, MD PhD FRCPC – The Hospital for Sick Children, Toronto